ArticleAdvances in rheumatology (London, England)2025
Platelet-to-lymphocyte ratio: a predictive biomarker for exocrine gland involvement in Sjögren disease.
Article in Advances in rheumatology (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The systemic immune-inflammation biomarkers in Sjögren's disease: associations with disease activity and extraglandular manifestations in a multicentric Italian cohort.Internal and emergency medicine · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo investigate the relationship between the platelet-to-lymphocyte ratio (PLR) and ocular surface damage as well as labial gland pathology in patients with Sjögren disease (SjD).
methodsThis retrospective study included 181 newly diagnosed SjD patients. Blood tests were used to calculate PLR, systemic immune-inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR), and fibrinogen-to-albumin ratio (FAR). All patients underwent comprehensive ocular surface examinations and labial gland biopsies. Spearman correlation analysis was used to evaluate the relationships between variables, and receiver operating characteristic (ROC) curves determined optimal cutoff values for PLR in predicting tear meniscus height (TMH) abnormality and labial gland pathology positivity. Mann-Whitney U tests identified potential risk factors for labial gland pathology positivity. The significant factors (P < 0.05) from the univariate analysis were incorporated into a binary logistic regression model to determine independent risk factors.
results(1) Correlation analysis showed that PLR was positively correlated with SII (r = 0.680, P < 0.001), NLR (r = 0.488, P < 0.001), FAR (r = 0.162, P = 0.031), and labial gland pathology (r = 0.159, P = 0.035), while PLR was negatively correlated with TMH (r=-0.202, P = 0.008). (2) ROC analysis revealed that PLR had an area under the curve (AUC) of 0.609 (95%CI: 0.522-0.695, p = 0.015) for predicting abnormal TMH, with a sensitivity of 48.6% and specificity of 74% at a cutoff of 151.34. For predicting labial gland pathology positivity, PLR had an AUC of 0.616 (95% CI: 0.503-0.730, p = 0.035), with a sensitivity of 65.7% and specificity of 58.8% at a cutoff of 122.92. (3) Binary logistic regression analysis showed that the high PLR group(PLR > 122.92) had 2.8 times the risk of labial gland pathology positivity compared to the low PLR group (OR = 2.842, 95%CI: 1.271-5.358, p = 0.011).
conclusionPLR is a useful inflammatory marker for evaluating exocrine gland involvement in SjD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.